Summary

The United Kingdom (UK) market for multiparameter patient monitoring (MPM) technologies is vibrant and promising. With a growing and ageing population as well as an increasing burden of chronic diseases, demand for improved MPM solutions is expected to skyrocket in the coming years. The population of the United Kingdom is rapidly ageing, with the number of people aged 65 and up predicted to reach 25% by 2040. This ageing population is increasingly susceptible to chronic diseases and requires continuing medical care, where MPM can help by monitoring vital signs and recognising potential issues early. The UK government recognises the relevance of MPM technology and has launched a number of measures to encourage its use in the healthcare system. This includes research and development funding, promotion of telehealth and remote patient monitoring, and encouragement of the use of interoperable MPM technologies. A growing interest in wearable and wireless devices, increased acceptance of cloud-based MPM solutions, and the integration of AI and machine learning algorithms for real-time data analysis and predictive diagnostics are some of the key trends affecting the UK MPM market. In the healthcare industry, data privacy and security are top priorities. In order to preserve the security and confidentiality of patient data, MPM solutions must adhere to stringent data protection requirements. Using MPM technology, the United Kingdom's healthcare sector is actively embracing remote patient monitoring (RPM). Initiatives such as the "NHS Long Term Plan" and the "Accelerated Access Collaborative" are encouraging the adoption of RPM for chronic disease management and post-hospital care, with the goal of improving patient outcomes and lowering hospital readmissions. In order to facilitate seamless data sharing between devices and healthcare IT infrastructure, the UK government is actively promoting interoperability standards for MPM systems. This programme, dubbed "OpenHealth," intends to improve patient care by removing data silos and allowing for better communication among healthcare experts.

According to the research report "United Kingdom Multiparameter Patient Monitoring Market Overview, 2028," published by Bonafide Research, the United Kingdom Multiparameter Patient Monitoring market is projected to grow with more than 4.50% CAGR from 2023 to 2028. Considering the increasing dependency on MPM technology, cybersecurity is a major worry. The UK government and healthcare organisations are investing extensively in cybersecurity solutions to protect sensitive patient data from cyber-attacks and to maintain healthcare information privacy and security. To keep up with technical improvements, the regulatory landscape for MPM in the UK is continually expanding. The Medicines and Healthcare Products Regulatory Agency (MHRA) is responsible for ensuring the safety and efficacy of MPM devices before they are placed on the market. To keep up with technical improvements, the regulatory landscape for MPM in the UK is continually expanding. The Medicines and Healthcare Products Regulatory Agency (MHRA) is responsible for ensuring the safety and efficacy of MPM devices before they are placed on the market. The United Kingdom is home to world-class research institutions and universities that drive healthcare technology innovation. These organisations work with industry partners to create cutting-edge multiparameter patient monitoring systems that use developments such as AI, machine learning, and data analytics. The National Health Service (NHS) is critical to shaping healthcare practices in the United Kingdom. The NHS's emphasis on quality, patient safety, and efficiency influences the adoption and use of multiparameter patient monitoring equipment across the country's healthcare facilities. The United Kingdom's investment in health informatics and electronic health records (EHRs) makes it possible to integrate multiparameter patient monitoring data into comprehensive patient records. This integration facilitates informed decision-making, care continuity, and population health management.

In terms of product segment market is bifurcated into portable and fixed. Fixed device type is projected to grow at rapid pace in United Kingdom multiparameter patient monitoring market. Hospital infrastructure in the United Kingdom is constantly being upgraded, including critical care units and specialised wards. This continuous infrastructure development includes the installation of fixed multiparameter patient monitoring equipment within these institutions. Within hospitals, fixed devices provide a standardised and uniform approach to patient monitoring. These devices are integrated into hospital processes and protocols to ensure consistency in monitoring practices across departments and facilitate effective healthcare delivery. Fixed monitoring devices are designed to achieve high accuracy and reliability standards, which are vital in critical care settings. Their precision and continuous monitoring capabilities contribute to their increasing acceptance in hospital settings. Fixed devices meet the needs of patients who require constant, long-term monitoring, such as those in critical condition or recovering from surgery. These gadgets ensure continuous patient assessment and care by providing uninterrupted monitoring. Fixed monitoring devices integrate smoothly into hospital workflows, allowing healthcare workers to manage and prioritise patient care more efficiently. They become essential components of the hospital's operational effectiveness, allowing for regular monitoring while minimising disruptions to normal operations.

Based on acuity level market is segmented into high-acuity level, medium-acuity level and low-acuity level. Low-acuity level multiparameter patient monitoring is projected to grow at significant in United Kingdom. A growing trend is to provide healthcare treatments outside of traditional hospital settings. Remote monitoring and home-based care for patients with chronic diseases are made possible by low-acuity monitoring devices, which ensure continuous monitoring while minimising the need for frequent hospital visits. Chronic disorders such as hypertension, diabetes, and respiratory ailments are becoming more common. Low-acuity level monitoring devices meet the demands of these patients by continuously monitoring vital signs, assisting in the early detection of variations, and empowering people to manage their diseases proactively. The growth of telemedicine and remote monitoring activities, particularly in the aftermath of the COVID-19 epidemic, has hastened the deployment of low-acuity monitoring equipment. These gadgets make remote consultations and continuous monitoring possible, increasing access to healthcare services. Patients are becoming more involved in managing their health. Low-acuity level monitoring devices empower patients by providing them with the tools to track their health parameters, fostering a sense of control and engagement in their healthcare journey.

Considered in this report:
• Geography: United Kingdom
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• United Kingdom Multiparameter Patient Monitoring market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Device:
• Portable
• Fixed

By Acuity Level:
• High-Acuity Level
• Medium Acuity Level
• Low Acuity Level

By End User:
• Hospital
• Homecare Settings
• Ambulatory Surgical Centers

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Multiparameter Patient Monitoring industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents